Treatment with a CD200 Receptor Agonist Aptamer Attenuates Airway Hyperresponsiveness, Airway Inflammation, and Remodelling in a Chronic Murine Model of HDM-Induced Airways Inflammation

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

AMER THORACIC SOC

1. Lung Association
2. Canadian Institutes for Health Research
3. CBCF studentship